AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05637567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Description: 100 mg per os once daily
Study NCT05637567 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill per os once daily
Study NCT05393895 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSF-1
Description: One drop bilaterally twice daily for approximately 6 weeks
Study NCT05393895 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: One drop bilaterally twice daily for approximately 6 weeks
Study NCT04835623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.09% Ophthalmic Solution
Description: one drop each eye twice daily
Study NCT06299670 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: Patients will get only Thalidomide
Study NCT06299670 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxy Urea
Description: Patients will get only Hydroxyurea
Study NCT06299670 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combinations
Description: Combination Of Thalidomide \& Hydroxyurea
Study NCT05260138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gentle Body message
Description: The intervention group received gentle body massage twice/day and position change from supine to lateral every two hours under the phototherapy for three consecutive days in addition to routine NICU care.
Study NCT06461390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: NE Group (Fluid loading with early norepinephrine administration group) NE Group will receive ringer lactate bolus 20 ml/kg along with norepinephrine infusion at 0.1 mcg/kg/minute until MAP\&gt;5 percentile. Additional fluid boluses of 10-20 ml/kg will be administered (up to a total of 60 ml/kg) until shock resolution or signs of fluid overload are observed, with or without continued norepinephrine infusion according to the treatment group
Study NCT06461390 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ringer's Lactate
Description: Fluid Group will receive ringer lactate bolus 20 ml/ kg only. Additional fluid boluses of 10-20 ml/kg will be administered (up to a total of 60 ml/kg) until shock resolution or signs of fluid overload are observed
Study NCT05260138 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine NICU Care
Description: received the conventional NICU care of infants undergoing phototherapy. Phototherapy was given by single Blue LEDs emitting light in a narrow spectrum (450-470 nm). Initially, phototherapy lamps were checked and adjusted at the height of 30 cm from the neonates who were kept naked in the incubator/crib except for the reproductive organs with shielded eyes. The neonates were positioned supine under the phototherapy. The treatment was given continuously, except while feeding and nursing for 30 minutes every 3 hours. The neonates' skin was cleaned with warm water without applying any sorts of ointments oils or creams. They were also observed for signs of dehydration.
Study NCT05468580 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Coeliac Artery Release (eCAR)
Description: Endoscopic Coeliac Artery Release (eCAR); The Median Arcuate Ligament will be cleaved via an endoscopic retroperitoneal approach using a 4 trocar technique described in detail by van Petersen (12). To rule out learning curves and procedural variation all the procedures will be performed by two experienced eCAR surgeons in the MST-Dutch Expert Centre of Gastrointestinal Ischemia. All procedures will be videotaped. Both eCAR surgeons will not be involved in the follow up procedures.
Study NCT05468580 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Operation
Description: The sham operation consists of making 4 incisions up to the fascia similar to endoscopic AC release (eCAR). After 60 to 75 minutes of general anesthesia, in accordance with the average operating time of eCAR, the sham operation is ended. This study design allows for patient and observer blinding and for the sham group the eCAR approach is still feasible if the CARoSO outcome support this without applying additional scar tissue.
Study NCT04970823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The somatosensory interactive game for preschool children
Description: The somatosensory interactive game, an independent nursing intervention, promotes pain relief for preschool children.
Study NCT04970823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A VR (virtual reality) game for school-age children
Description: A VR (virtual reality) game environment promotes pain relief for school-age children.
Study NCT05556083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sildenafil 50 mg Oral Tablet and Dapoxitine 3mg Oral tablet
Description: Single blind placebo randomized controlled trial
Study NCT05556083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet and Dapoxitine 3mg Oral tablet
Description: Single blind placebo randomized controlled trial
Study NCT05306834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Retinal Imaging
Description: Auto-Refractometry / Adaptative Optics (OA) / Swept Source Optical Coherence Tomography (SS-OCT-A) / Globe Axial length measurements / Color Retinophotography of the retina.
Study NCT05306834 — intervention group
Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: Blood sample
Description: Analyses of molecular biomarkers including
Study NCT05306834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of cardiovascular risks
Description: Measurement of blood pressure and arterial stiffness
Study NCT05306834 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Brain imaging (MRI)
Description: 3DT1 / 3DFLAIR / T2GRE / DTI 15 directions (and B0MAP)
Study NCT05306834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Tests
Description: Mini Mental State Examination (MMSE) / Montreal Cognitive Assessment (MoCA) / 16 items Free and Cued Recall (RL/RI 16 items) / Trail Making Test A et B (TMT A et B) / Frontal Assessment Battery (FAB) / Phonemic (letter P) and semantic (animals) verbal fluency tests / Digit Symbol Substitution Test (DSST)
Study NCT05306834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Geriatric Depression Scale (GDS)
Description: 15 items
Study NCT05306834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Instrumental Activities of Daily Living (IADL)
Description: Instrumental Activities of Daily Living (IADL)
Study NCT06052436 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic thyTreg 5.000.000
Description: Treg lymphocytic cells, differentiated, allogeneic, of thymic tissue, expanded and stimulated with Interleukin (IL-) 2 (thyTreg)
Study NCT06052436 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic thyTreg 10.000.000
Description: Treg lymphocytic cells, differentiated, allogeneic, of thymic tissue, expanded and stimulated with Interleukin (IL-) 2 (thyTreg)
Study NCT05306834 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Unipodal standing test
Description: Unipodal standing test
Study NCT05306834 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking speed measurement
Description: over 5 meters
Study NCT04829006 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Understand Me For Life
Description: The aim of the current investigation is to test the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Study NCT05813015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel 40mg/m2，every 21 days，6 cycles.
Study NCT05813015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegafur-Gimeracil-Oteracil
Description: S-1 40-60mg/m2，p.o, BID, day 1-14, till 1 year postoperation.
Study NCT05471778 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Watching comedy movie
Description: A 25-minute comedy film created by the researchers was watched.
Study NCT05471778 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: listening to music
Description: 25 minutes of music created by the researchers was played.
Study NCT04979793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-citrulline
Description: 3 gram sachet, L-citrulline
Study NCT04718051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Shen Pu Yang Gan Wan
Description: Shen Pu Yang Gan Wan is Traditional Chinese Medicine; in addition, it has a high dose.
Study NCT04718051 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Shen Pu Yang Gan Wan is Traditional Chinese Medicine; however, it has a very low dose.
Study NCT04979793 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Milk powder placebo
Study NCT05047302 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BlueLeaf Procedure
Description: The device is intended to form autogenous tissue leaflets from vein walls without the use of a permanent vascular implant.
Study NCT03421028 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electromyography Biofeedback
Description: EMG-Biofeedback- assisted training is a method in which electrodes situated on the surface of the skin detect small voltage changes which arise from the working muscles (in this case masseter and temporalis muscles). The voltage is transformed into a visual or sound time-variable signal which gives the patient feedback as he willingly tries to change the muscle tension (in this case to lower the excessive masseter tension)
Study NCT03421028 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic treatment for myogenous TMD
Description: Combination of physiotherapy (manual therapy), stabilization occlusal splint usage and counseling
Study NCT05265234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: IL-4 antagonist to improve moderate-severe atopic dermatitis
Study NCT05265234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optical Coherence Tomography
Description: OCT is a noninvasive imaging device that can be used to monitor inflammatory skin disorders.
Study NCT05265234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reflectance confocal microscopy
Description: RCM is a noninvasive imaging device, with resolution approaching that of histology, which can monitor structural changes in the epidermis and superficial dermis, monitor inflammatory cells, and can overcome the limitations of a traditional biopsy.
Study NCT05541250 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Human Schwann Cell
Description: A one-time dose of 1000 μl\* or 80 to 100 million ahSC prepared from segments of the sural nerve from the leg recovered from the participant.
Study NCT04957745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Binocular visual confusion (unilateral opaque)
Description: The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation.~For the binocular visual confusion condition, the non-transparent (opaque) peripheral target will be displayed on only one eye (unilateral opaque display).
Study NCT04957745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unilateral monocular visual confusion (unilateral see-through)
Description: The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation.~For the unilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on only one eye (unilateral see-through display).
Study NCT04957745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bilateral monocular visual confusion (bilateral see-through)
Description: The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation.~For bilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on both eyes (bilateral see-through display).
Study NCT05368389 — intervention group
Intervention type: DEVICE
Intervention: Healthdot attachment
Description: The wearable health monitoring device Healthdot 5 will be attached to the patient's skin at left lower rib and data like heart rate, respiratory rate, posture and activity will be collected for 10 days.~A questionnaire will be sent to patients to fill out at the 10th day after the device attachment.
Study NCT06129591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazarus Naturals THC-Free CBD Tincture (flavorless) + Silicone patch
Description: The study intervention is prospective in nature. This split scar study directly compares two parts of the healing scar during clinic visits. Photos will be taken at each visit to track progress. Assessment will be done over a period of 6 months using the Modified Patient and Observer Scar Assessment Scale, followed by blinded photo evaluations using the Scar Cosmesis and Rating Scale. Statistical analysis will assess whether CBD oil improves short-term and long-term scar appearances.
Study NCT06129591 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Silicone patch
Description: A non-treatment group is included in this study to comply with the standard of care, as to treat post-operative wounds with silicone patches to improve final scar outcomes.
Study NCT05786391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flat position
Description: Flat patient position during the cystoscopy
Study NCT05786391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trendelenburg position
Description: Trendelenburg position (head down) during the cystoscopy
Study NCT05786391 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insufflation
Description: Insufflation to 15 mm Hg
Study NCT04897308 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local injection of shoulder joint
Description: Under ultrasound guidance , local shoulder joint injection will be done
Study NCT06327347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intraocular lens implantation in cataract surgery
Description: Implantation of intra ocular lenses in both patient's eyes in remplacement of the natural cataracted cristallin that has been removed from the patient's eye during the cataract surgery
Study NCT06333145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Exploring ED90 induced by remimazolam anesthesia in adults of different BMI groups undergoing drug-induced sleep endoscopy
Study NCT05834660 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safe Alternatives for Teens and Youth-Acute for Schools (SAFETY-A for Schools)
Description: SAFETY-A is a brief, family centered, cognitive-behavioral approach to therapeutic risk assessment and safety planning that can be delivered via school-based providers. The intervention is delivered in one session during which the youth at risk for suicidal behavior works with the provider to identify strengths, supports, understand emotional antecedents and warning signs, identify alternative coping behaviors and thoughts, and ways to keep the environment safe. Youth and families receive follow-up contacts by phone at 1, 2, and 4 weeks after the SAFETY-A session. The primary focus is on the therapeutic mechanisms of hope, reduced intensity of suicidal urges, increased confidence in ability to keep safe. Adaptation of SAFETY-A for Schools will target mechanisms that are presumed to drive disparities in mental health service use among Asian American and Latinx youth: (1) trust in mental health services, (2) internalized stigma, and (3) comfort communicating distress.
Study NCT05407402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: laughter yoga practice
Description: To reduce the pain and increase the comfort of individuals diagnosed with migraine with these planned interventions.
Study NCT05407402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: watching funny videos
Description: To reduce the pain and increase the comfort of individuals diagnosed with migraine with these planned interventions.
Study NCT04616378 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Phase 2 Prescribed Prosthesis
Description: Everyday used prosthesis that was prescribed by their physician.
Study NCT04616378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 2 Robotic Prosthetic Leg
Description: The RPL consists of a passive-dynamic ankle, powered knee, and an on-board inertial measurement sensors with an on-board kinetic and kinematic data collection system for analysis.
Study NCT04616378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 3 No Prosthesis
Description: No prosthetic device is attached.
Study NCT04616378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 3 Robotic Prosthetic Leg
Description: The RPL consists of a passive-dynamic ankle, powered knee, and an on-board inertial measurement sensors with an on-board kinetic and kinematic data collection system for analysis.
Study NCT04616378 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Phase 3 Prescribed Prosthesis
Description: Everyday used prosthesis that was prescribed by their physician.
Study NCT04842266 — intervention group
Intervention type: DEVICE
Intervention: IlluminOss pelvic implant for oncologic indication
Description: Impending or actual non-displaced or minimally displaced pathologic fractures of the pelvis
Study NCT04842266 — intervention group
Intervention type: DEVICE
Intervention: IlluminOss pelvic implant for geriatric trauma indication
Description: Pelvic fragility fracture in a geriatric patients (age 65 or older)
Study NCT05077722 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Garmin
Description: A smartwatch device that measures subjects level of activity, heartrate, respirations and quality of your sleep at night. Artificial intelligence will be applied to analyze all the data over the course of 12 weeks to monitor and attempt to predict the onset of tantrums or disruptive behavior. Subjects are required to wear the watch at least 70% of the day and night each day for 70% of days during 12 weeks of treatment.
Study NCT05077722 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Garmin
Description: A smartwatch device that measures subjects level of activity, heartrate, respirations and quality of your sleep at night. Artificial intelligence will be applied to analyze all the data over the course of 12 weeks to monitor and attempt to predict the onset of tantrums or disruptive behavior. Subjects are required to wear the watch at least 70% of the day and night each day for 70% of days during 12 weeks of treatment.
Study NCT04540354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Optimal Medical Therapy (OMT)
Description: Patients will be treated according to Optimal Medical Therapy defined by the 2016 ESC guidelines for the management of acute and chronic heart failure.
Study NCT04540354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimal Medical Therapy (OMT)
Description: Patients will be treated according to Optimal Medical Therapy defined by the 2016 ESC guidelines for the management of acute and chronic heart failure.
Study NCT04540354 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD)
Description: An ICD consists of an electronic medical device and electrode leads. The surgery can be performed in local anaesthesia, but a short general anaesthesia is required if the ICD has to be tested giving the patient an electric shock. Besides the possibility to shock during arrhythmias the ICD can potentially terminate ventricular tachycardias by rapid pacing for short periods (small bursts of pacing).~The subcutaneous defibrillator is an established and valid alternative to the conventional ICD for the preven-tion of SCD. According to current guidelines, the subcutaneous defibrillator should be considered as an alternative to transvenous defibrillators in patients with an indication for an ICD when pacing therapy for bradycardia support, cardiac resynchronisation or antitachycardia pacing is not needed.
Study NCT06220188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [177Lu]Lu-PSMA I&T
Description: 2 cycles (3 GBq in first cycle and 6 GBq in the second cycle) of \[177Lu\]Lu-PSMAI\&T radioligand therapy at 6-week intervals
Study NCT05833061 — intervention group
Intervention type: OTHER
Intervention: The Stroke-Specific Quality of Life (SS-QoL) scale
Description: The Stroke-Specific Quality of Life (SS-QoL) scale is a questionnaire-based tool that is used to assess the quality of life of individuals who have experienced a stroke. It was developed to evaluate the impact of stroke on various domains of life, including physical, psychological, and social aspects. The SS-QoL scale contains 49 items, which are organized into 12 domains such as mobility, self-care, work/productivity, language, social roles, and emotional well-being. The scale has been validated and is widely used by healthcare professionals and researchers to assess the effectiveness of interventions and treatments for stroke patients, as well as to evaluate the long-term impact of stroke on their quality of life.